Skip to main content

Advertisement

Log in

Study of the Association of Polymorphisms of p53 and p21 with the Risk of Development of Stomach Cancer

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

A real-time PCR with hybridization and fluorescent detection was used to analyze the distribution of p53 G215C, p21A1026G, and G369C gene polymorphisms in patients with stomach cancer and healthy subjects. It was found that allele C, genotypes of CC and GC of G215C p53, and G369C p21 polymorphisms and allele A and AA and GA genotypes of A1026G p21 polymorphism are significantly associated with the risk of stomach cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dmitrieva AI, Serebryakova VA, Kuznetsova IA, Rakitin SS, Kudyakov LA, Novitskii VV. Identification of polymorphic variants of cell cycle regulator genes in lung carcinoma. Tuberkulez Bol. Legkhikh. 2015;93(10):50-53. Russian.

    Google Scholar 

  2. Kuznetsova IA, Dmitrieva AI, Rakitin SS, Novitski VV. Polymorhism of genes of cell cycle regulators P53 AND P21 in lung cancer. Sib. Med. Zh. (Irkutsk). 2012;110(3):47-50. Russian.

    Google Scholar 

  3. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer. 2009;9(6):400-414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J. Biomed. Biotechnol. 2012;2012. ID 891961. doi: https://doi.org/10.1155/2012/891961.

  5. Cañas M, Morán Y, Camargo ME, Rivero M.B, Bohórquez A, Villegas V, Ramírez E, Rendón Y, Suárez A, Morales L, Useche E, Salazar S, Zambrano A, Ramírez A, Valderrama E, Briceño Z, Chiurillo MA. TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela. Invest. Clin. 2009;50(2):153-161.

    PubMed  Google Scholar 

  6. Chen Z, Dong Y, Wang N, Liang H, Du Y, Ye X, Jia W, He Z, Jiang Y, Yang Y, Yang W. A novel tri-allelic insertion/deletion polymorphism in the promoter of p21(Waf1/Cip1) and the association with gastric cancer. Genet. Test. Mol. Biomarkers. 2014;18(2):112-116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int. J. Cancer. 2011;129(4):920-930.

    Article  CAS  PubMed  Google Scholar 

  8. Joerger AC, Fersht AR. Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene. 2007;26(15):2226-2242.

    Article  CAS  PubMed  Google Scholar 

  9. Ke-Xiang Z, Yu-Min L, Xun L, Wen-Ce Z, Yong S, Tao L. Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China. Mol. Biol Rep. 2011;39(1):723-728.

    Article  PubMed  Google Scholar 

  10. Martinez-Rivera M, Siddik ZH. Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53. Biochem. Pharmacol. 2012;83(8):1049-1062.

    Article  CAS  PubMed  Google Scholar 

  11. Saxena A, Shukla SK, Prasad KN, Ghoshal UC. Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north India. Indian J. Med. Res. 2012;136(4):664-670.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Schmidt MK, Tommiska J, Broeks A, van Leeuwen FE, Van’t Veer LJ, Pharoah PD, Easton DF, Shah M, Humphreys M, Dörk T, Reincke SA, Fagerholm R, Blomqvist C, Nevanlinna H. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP 309, and p53 expression on survival of breast cancer patients. Breast Cancer Res. 2009;11(6):R89.

  13. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol. Rep. 2004;11(5):1115-1120.

    CAS  PubMed  Google Scholar 

  14. Song HR, Kweon SS, Kim HN, Piao JM, Yun WJ, Choi JS, Hwang JE, Yoon JY, Kim HR, Park YK, Kim SH, Choi YD, Shin MH. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer. 2011;14(3):248.

    Article  Google Scholar 

  15. Wang C, Chen Z, Ye Z. Small RNAs inhibit bladder cancer by up-regulating tumor suppressor genes. RNA Dis. 2015;2:e595. doi: 10.14800/rd.595.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Dmitrieva.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 7, pp. 110-114, July, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dmitrieva, A.I., Serebryakova, V.A., Rakitin, S.S. et al. Study of the Association of Polymorphisms of p53 and p21 with the Risk of Development of Stomach Cancer. Bull Exp Biol Med 164, 95–98 (2017). https://doi.org/10.1007/s10517-017-3932-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3932-6

Key Words

Navigation